CEMI
Price:
$0.455
Market Cap:
$16.71M
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professiona...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2000-10-18
Stock Exchange
NASDAQ
Ticker
CEMI
According to Chembio Diagnostics, Inc.’s latest financial reports and current stock price. The company's current ROE is -89.47%. This represents a change of 223.95% compared to the average of -27.62% of the last 4 quarters.
The mean historical ROE of Chembio Diagnostics, Inc. over the last ten years is -54.54%. The current -89.47% ROE has changed 64.05% with respect to the historical average. Over the past ten years (40 quarters), CEMI's ROE was at its highest in in the September 2013 quarter at 3.51%. The ROE was at its lowest in in the June 2016 quarter at -91.10%.
Average
-54.54%
Median
-52.81%
Minimum
-130.86%
Maximum
2.63%
Discovering the peaks and valleys of Chembio Diagnostics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 472.77%
Maximum Annual ROE = 2.63%
Minimum Annual Increase = -319.16%
Minimum Annual ROE = -130.86%
| Year | ROE | Change |
|---|---|---|
| 2022 | -130.86% | 32.25% |
| 2021 | -98.95% | 7.69% |
| 2020 | -91.88% | 61.49% |
| 2019 | -56.90% | 140.64% |
| 2018 | -23.64% | -51.47% |
| 2017 | -48.72% | -37.33% |
| 2016 | -77.74% | 472.77% |
| 2015 | -13.57% | 135.40% |
| 2014 | -5.77% | -319.16% |
| 2013 | 2.63% | -61.22% |
The current ROE of Chembio Diagnostics, Inc. (CEMI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-107.23%
5-year avg
-80.44%
10-year avg
-54.54%
Chembio Diagnostics, Inc.’s ROE is greater than Enzo Biochem, Inc. (-43.52%), greater than Psychemedics Corporation (-21.57%), less than Titan Medical Inc. (857.87%), greater than Conformis, Inc. (-65.24%), greater than 23andMe Holding Co. (-552.02%), less than Kineta, Inc. (71.50%), greater than Lucira Health, Inc. (-102.50%), greater than Pieris Pharmaceuticals, Inc. (-58.40%), greater than Aesthetic Medical International Holdings Group Limited (-50.27%), greater than AlphaTON Capital Corp. (-738.96%),
| Company | ROE | Market cap |
|---|---|---|
| -43.52% | $36.59M | |
| -21.57% | $15.74M | |
| 857.87% | $15.66M | |
| -65.24% | $17.88M | |
| -552.02% | $13.34M | |
| 71.50% | $7.05M | |
| -102.50% | $18.36M | |
| -58.40% | $17.96M | |
| -50.27% | $15.93M | |
| -738.96% | $3.83M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chembio Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chembio Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Chembio Diagnostics, Inc.'s ROE?
How is the ROE calculated for Chembio Diagnostics, Inc. (CEMI)?
What is the highest ROE for Chembio Diagnostics, Inc. (CEMI)?
What is the 3-year average ROE for Chembio Diagnostics, Inc. (CEMI)?
What is the 5-year average ROE for Chembio Diagnostics, Inc. (CEMI)?
How does the current ROE for Chembio Diagnostics, Inc. (CEMI) compare to its historical average?